• Boston University School of Medicine
• 14 Apr, 2021

How could studying gastrointestinal cells help the fight against COVD-19, which is a respiratory disease? According to a team led by Gustavo Mostoslavsky, MD, PhD, at the BU/BMC Center for Regenerative Medicine (CReM) and Elke Mühlberger, PhD, from the National Emerging Infectious Diseases Laboratories (NEIDL), testing how SARS-CoV-2 affects the gut can potentially serve to test novel therapeutics for COVID-19.
Read more...